Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Intravitreal Injectable Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturer

Published by QYResearch Product code 998727
Published Content info 112 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Intravitreal Injectable Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturer
Published: April 6, 2021 Content info: 112 Pages
Description

Market Analysis and Insights: Global Intravitreal Injectable Market

In 2020, the global Intravitreal Injectable market size was US$ 13.72 billion and it is expected to reach US$ 21.96 billion by the end of 2027, with a CAGR of 7.13% between 2021 and 2027.

Global Intravitreal Injectable Scope and Market Size

The global Intravitreal Injectable market is segmented by region (country), company, by Drug, and by Disease. Players, stakeholders, and other participants in the global Intravitreal Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Drug, and by Disease for the period 2016-2027.

By Company

  • Regeneron Pharmaceuticals (Eylea)
  • Allergan
  • EyePoint Pharmaceuticals
  • Genentech
  • Kanghong Pharmaceutical

Segment by Drug

  • Anti-VEGF
  • Steroids
  • Others

Segment by Disease

  • Macular Degeneration
  • Nacular Edema
  • Uveitis
  • Retinal Vein Occlusion
  • Others

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • Korea
  • India
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Middle East
  • Africa
Table of Contents

TABLE OF CONTENTS

1 INTRAVITREAL INJECTABLE MARKET OVERVIEW

  • 1.1 Intravitreal Injectable Product Overview
  • 1.2 Intravitreal Injectable Market Segment by Drug
    • 1.2.1 Anti-VEGF
    • 1.2.2 Steroids
    • 1.2.3 Others
  • 1.3 Global Intravitreal Injectable Market Size by Drug
    • 1.3.1 Global Intravitreal Injectable Market Size Overview by Drug (2016-2027)
    • 1.3.2 Global Intravitreal Injectable Historic Market Size Review by Drug (2016-2021)
      • 1.3.2.1 Global Intravitreal Injectable Sales Breakdown in Volume, by Drug (2016-2021)
      • 1.3.2.2 Global Intravitreal Injectable Sales Breakdown in Value, by Drug (2016-2021)
      • 1.3.2.3 Global Intravitreal Injectable Average Selling Price (ASP) by Drug (2016-2021)
    • 1.3.3 Global Intravitreal Injectable Forecasted Market Size by Drug (2022-2027)
      • 1.3.3.1 Global Intravitreal Injectable Sales Breakdown in Volume by Drug (2022-2027)
      • 1.3.3.2 Global Intravitreal Injectable Sales Breakdown in Value by Drug (2022-2027)
      • 1.3.3.3 Global Intravitreal Injectable Average Selling Price (ASP) by Drug (2022-2027)
  • 1.4 Key Regions Market Size Segment by Drug
    • 1.4.1 North America Intravitreal Injectable Sales Breakdown by Drug (2016-2021)
    • 1.4.2 Europe Intravitreal Injectable Sales Breakdown by Drug (2016-2021)
    • 1.4.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Drug (2016-2021)
    • 1.4.4 Latin America Intravitreal Injectable Sales Breakdown by Drug (2016-2021)
    • 1.4.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Drug (2016-2021)

2 INTRAVITREAL INJECTABLE MARKET COMPETITION BY COMPANY

  • 2.1 Global Top Players by Intravitreal Injectable Sales (2018-2020)
  • 2.2 Global Top Players by Intravitreal Injectable Revenue (2018-2020)
  • 2.3 Global Top Players by Intravitreal Injectable Price (2018-2020)
  • 2.4 Global Top Manufacturers Intravitreal Injectable Headquarters, Sales Area
  • 2.5 Intravitreal Injectable Market Competitive Situation
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2020)
  • 2.7 Mergers & Acquisitions, Expansion

3 INTRAVITREAL INJECTABLE STATUS AND OUTLOOK BY REGION

  • 3.1 Global Intravitreal Injectable Market Size and CAGR by Region: 2016 VS 2021 VS 2027
  • 3.2 Global Intravitreal Injectable Historic Market Size by Region
    • 3.2.1 Global Intravitreal Injectable Sales in Volume by Region (2016-2021)
    • 3.2.2 Global Intravitreal Injectable Sales in Value by Region (2016-2021)
    • 3.2.3 Global Intravitreal Injectable Sales (Volume & Value), Price and Gross Margin (2016-2021)
  • 3.3 Global Intravitreal Injectable Forecasted Market Size by Region
    • 3.3.1 Global Intravitreal Injectable Sales in Volume by Region (2022-2027)
    • 3.3.2 Global Intravitreal Injectable Sales in Value by Region (2022-2027)
    • 3.3.3 Global Intravitreal Injectable Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 INTRAVITREAL INJECTABLE BY DISEASE

  • 4.1 Intravitreal Injectable Market Segment by Disease
    • 4.1.1 Macular Degeneration
    • 4.1.2 Nacular Edema
    • 4.1.3 Uveitis
    • 4.1.4 Retinal Vein Occlusion
    • 4.1.5 Others
  • 4.2 Global Intravitreal Injectable Market Size by Disease
    • 4.2.1 Global Intravitreal Injectable Market Size Overview by Disease (2016-2027)
    • 4.2.2 Global Intravitreal Injectable Historic Market Size Review by Disease (2016-2021)
      • 4.2.2.1 Global Intravitreal Injectable Sales Breakdown in Volume, by Disease (2016-2021)
      • 4.2.2.2 Global Intravitreal Injectable Sales Breakdown in Value, by Disease (2016-2021)
      • 4.2.2.3 Global Intravitreal Injectable Average Selling Price (ASP) by Disease (2016-2021)
    • 4.2.3 Global Intravitreal Injectable Forecasted Market Size by Disease (2022-2027)
      • 4.2.3.1 Global Intravitreal Injectable Sales Breakdown in Volume by Disease (2022-2027)
      • 4.2.3.2 Global Intravitreal Injectable Sales Breakdown in Value by Disease (2022-2027)
      • 4.2.3.3 Global Intravitreal Injectable Average Selling Price (ASP) by Disease (2022-2027)
  • 4.3 Key Regions Market Size Segment by Disease
    • 4.3.1 North America Intravitreal Injectable Sales Breakdown by Disease (2016-2021)
    • 4.3.2 Europe Intravitreal Injectable Sales Breakdown by Disease (2016-2021)
    • 4.3.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Disease (2016-2021)
    • 4.3.4 Latin America Intravitreal Injectable Sales Breakdown by Disease (2016-2021)
    • 4.3.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Disease (2016-2021)

5 NORTH AMERICA INTRAVITREAL INJECTABLE BY COUNTRY

  • 5.1 North America Intravitreal Injectable Historic Market Size by Country
    • 5.1.1 North America Intravitreal Injectable Sales in Volume by Country (2016-2021)
    • 5.1.2 North America Intravitreal Injectable Sales in Value by Country (2016-2021)
  • 5.2 North America Intravitreal Injectable Forecasted Market Size by Country
    • 5.2.1 North America Intravitreal Injectable Sales in Volume by Country (2022-2027)
    • 5.2.2 North America Intravitreal Injectable Sales in Value by Country (2022-2027)

6 EUROPE INTRAVITREAL INJECTABLE BY COUNTRY

  • 6.1 Europe Intravitreal Injectable Historic Market Size by Country
    • 6.1.1 Europe Intravitreal Injectable Sales in Volume by Country (2016-2021)
    • 6.1.2 Europe Intravitreal Injectable Sales in Value by Country (2016-2021)
  • 6.2 Europe Intravitreal Injectable Forecasted Market Size by Country
    • 6.2.1 Europe Intravitreal Injectable Sales in Volume by Country (2022-2027)
    • 6.2.2 Europe Intravitreal Injectable Sales in Value by Country (2022-2027)

7 ASIA-PACIFIC INTRAVITREAL INJECTABLE BY REGION

  • 7.1 Asia-Pacific Intravitreal Injectable Historic Market Size by Region
    • 7.1.1 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2016-2021)
    • 7.1.2 Asia-Pacific Intravitreal Injectable Sales in Value by Region (2016-2021)
  • 7.2 Asia-Pacific Intravitreal Injectable Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2022-2027)
    • 7.2.2 Asia-Pacific Intravitreal Injectable Sales in Value by Region (2022-2027)

8 LATIN AMERICA INTRAVITREAL INJECTABLE BY COUNTRY

  • 8.1 Latin America Intravitreal Injectable Historic Market Size by Country
    • 8.1.1 Latin America Intravitreal Injectable Sales in Volume by Country (2016-2021)
    • 8.1.2 Latin America Intravitreal Injectable Sales in Value by Country (2016-2021)
  • 8.2 Latin America Intravitreal Injectable Forecasted Market Size by Country
    • 8.2.1 Latin America Intravitreal Injectable Sales in Volume by Country (2022-2027)
    • 8.2.2 Latin America Intravitreal Injectable Sales in Value by Country (2022-2027)

9 MIDDLE EAST AND AFRICA INTRAVITREAL INJECTABLE BY COUNTRY

  • 9.1 Middle East and Africa Intravitreal Injectable Historic Market Size by Country
    • 9.1.1 Middle East and Africa Intravitreal Injectable Sales in Volume by Country (2016-2021)
    • 9.1.2 Middle East and Africa Intravitreal Injectable Sales in Value by Country (2016-2021)
  • 9.2 Middle East and Africa Intravitreal Injectable Forecasted Market Size by Country
    • 9.2.1 Middle East and Africa Intravitreal Injectable Sales in Volume by Country (2022-2027)
    • 9.2.2 Middle East and Africa Intravitreal Injectable Sales in Value by Country (2022-2027)

10 COMPANY PROFILES AND KEY FIGURES IN INTRAVITREAL INJECTABLE BUSINESS

  • 10.1 Regeneron Pharmaceuticals (Eylea)
    • 10.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
    • 10.1.2 Regeneron Pharmaceuticals (Eylea) Introduction and Business Overview
    • 10.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2020)
    • 10.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Products Offered
  • 10.2 Genentech
    • 10.2.1 Genentech Corporation Information
    • 10.2.2 Genentech Introduction and Business Overview
    • 10.2.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2020)
    • 10.2.4 Genentech Intravitreal Injectable Products Offered
  • 10.3 Allergan (Ozurdex)
    • 10.3.1 Allergan (Ozurdex) Corporation Information
    • 10.3.2 Allergan (Ozurdex) Introduction and Business Overview
    • 10.3.3 Allergan (Ozurdex) Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2020)
    • 10.3.4 Allergan (Ozurdex) Intravitreal Injectable Products Offered
  • 10.4 EyePoint Pharmaceuticals
    • 10.4.1 EyePoint Pharmaceuticals Corporation Information
    • 10.4.2 EyePoint Pharmaceuticals Introduction and Business Overview
    • 10.4.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2020)
    • 10.4.4 EyePoint Pharmaceuticals Intravitreal Injectable Products Offered
  • 10.5 Kanghong Pharmaceutical
    • 10.5.1 Kanghong Pharmaceutical Corporation Information
    • 10.5.2 Kanghong Pharmaceutical Introduction and Business Overview
    • 10.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2020)
    • 10.5.4 Kanghong Pharmaceutical Intravitreal Injectable Products Offered

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 Intravitreal Injectable Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Intravitreal Injectable Industrial Chain Analysis
  • 11.4 Intravitreal Injectable Market Dynamics
    • 11.4.1 Industry Trends
    • 11.4.2 Market Drivers
    • 11.4.3 Market Challenges
  • 11.5 Porter's Five Forces Analysis

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 Sales Channel
  • 12.2 Intravitreal Injectable Distributors
  • 12.3 Intravitreal Injectable Downstream Customers

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
      • 14.1.1.1 Research Programs/Design
      • 14.1.1.2 Market Size Estimation
      • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
      • 14.1.2.1 Secondary Sources
      • 14.1.2.2 Primary Sources
  • 14.2 Author Details
  • 14.3 Disclaimer

List of Tables and Figures

  • Table 1. Global Intravitreal Injectable Sales by Drug: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 2. Global Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)
  • Table 3. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2016-2021)
  • Table 4. Global Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 5. Global Intravitreal Injectable Sales Market Share in Value by Drug (2016-2021)
  • Table 6. Global Intravitreal Injectable Price by Drug (2016-2021) & (USD/Unit)
  • Table 7. Global Intravitreal Injectable Sales by Drug (2022-2027) & (K Units)
  • Table 8. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2022-2027)
  • Table 9. Global Intravitreal Injectable Sales by Drug (2022-2027) & (US$ Million)
  • Table 10. Global Intravitreal Injectable Sales Market Share in Value by Drug (2022-2027)
  • Table 11. Global Intravitreal Injectable Price by Drug (2022-2027) & (USD/Unit)
  • Table 12. North America Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)
  • Table 13. North America Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 14. Europe Intravitreal Injectable Sales (K Units) by Drug (2016-2021)
  • Table 15. Europe Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 16. Asia-Pacific Intravitreal Injectable Sales (K Units) by Drug (2016-2021)
  • Table 17. Asia-Pacific Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 18. Latin America Intravitreal Injectable Sales (K Units) by Drug (2016-2021)
  • Table 19. Latin America Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 20. Middle East and Africa Intravitreal Injectable Sales (K Units) by Drug (2016-2021)
  • Table 21. Middle East and Africa Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)
  • Table 22. Global Intravitreal Injectable Sales by Company (2018-2020) & (K Units)
  • Table 23. Global Intravitreal Injectable Sales Share by Company (2018-2020)
  • Table 24. Global Intravitreal Injectable Revenue by Company (2018-2020) & (US$ Million)
  • Table 25. Global Intravitreal Injectable Revenue Share by Company (2018-2020)
  • Table 26. Global Market Intravitreal Injectable Price by Company (2018-2020) & (USD/Unit)
  • Table 27. Global Intravitreal Injectable Top Manufacturers Headquarters and Sales Area
  • Table 28. Global Intravitreal Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2020)
  • Table 30. Mergers & Acquisitions, Expansion Plans
  • Table 31. Global Intravitreal Injectable Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
  • Table 32. Global Intravitreal Injectable Sales by Region (2016-2021) & (K Units)
  • Table 33. Global Intravitreal Injectable Sales Market Share in Volume by Region (2016-2021)
  • Table 34. Global Intravitreal Injectable Sales by Region (2016-2021) & (US$ Million)
  • Table 35. Global Intravitreal Injectable Sales Market Share in Value by Region (2016-2021)
  • Table 36. Global Intravitreal Injectable Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
  • Table 37. Global Intravitreal Injectable Sales by Region (2022-2027) & (K Units)
  • Table 38. Global Intravitreal Injectable Sales Market Share in Volume by Region (2022-2027)
  • Table 39. Global Intravitreal Injectable Sales by Region (2022-2027) & (US$ Million)
  • Table 40. Global Intravitreal Injectable Sales Market Share in Value by Region (2022-2027)
  • Table 41. Global Intravitreal Injectable Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027)
  • Table 42. Global Intravitreal Injectable Sales by Disease: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 43. Global Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
  • Table 44. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2016-2021)
  • Table 45. Global Intravitreal Injectable Sales by Disease (2016-2021) & (US$ Million)
  • Table 46. Global Intravitreal Injectable Sales Market Share in Value by Disease (2016-2021)
  • Table 47. Global Intravitreal Injectable Price by Disease (2016-2021) & (USD/Unit)
  • Table 48. Global Intravitreal Injectable Sales by Disease (2022-2027) & (K Units)
  • Table 49. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2022-2027)
  • Table 50. Global Intravitreal Injectable Sales by Disease (2022-2027) & (US$ Million)
  • Table 51. Global Intravitreal Injectable Sales Market Share in Value by Disease (2022-2027)
  • Table 52. Global Intravitreal Injectable Sales Market Share in Value by Disease (2022-2027)
  • Table 53. Global Intravitreal Injectable Price by Disease (2022-2027) & (USD/Unit)
  • Table 54. North America Intravitreal Injectable Sales by Disease (2016-2021) & (K Units)
  • Table 55. North America Intravitreal Injectable Sales Market Share in Volume (2016-2021)
  • Table 56. Europe Intravitreal Injectable Sales (K Units) by Disease (2016-2021)
  • Table 57. Europe Intravitreal Injectable Sales Market Share in Volume (2016-2021)
  • Table 58. Asia-Pacific Intravitreal Injectable Sales (K Units) by Disease (2016-2021)
  • Table 59. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume (2016-2021)
  • Table 60. Latin America Intravitreal Injectable Sales (K Units) by Disease (2016-2021)
  • Table 61. Latin America Intravitreal Injectable Sales Market Share in Volume (2016-2021)
  • Table 62. Middle East and Africa Intravitreal Injectable Sales (K Units) by Disease (2016-2021)
  • Table 63. Middle East and Africa Intravitreal Injectable Sales Market Share in Volume (2016-2021)
  • Table 64. North America Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
  • Table 65. North America Intravitreal Injectable Sales Market Share in Volume by Country (2016-2021)
  • Table 66. North America Intravitreal Injectable Sales by Country (2016-2021) & (US$ Million)
  • Table 67. North America Intravitreal Injectable Sales Market Share in Value by Country (2016-2021)
  • Table 68. North America Intravitreal Injectable Sales by Country (2022-2027) & (K Units)
  • Table 69. North America Intravitreal Injectable Sales Market Share in Volume by Country (2022-2027)
  • Table 70. North America Intravitreal Injectable Sales by Country (2022-2027) & (US$ Million)
  • Table 71. North America Intravitreal Injectable Sales Market Share in Value by Country (2022-2027)
  • Table 72. Europe Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
  • Table 73. Europe Intravitreal Injectable Sales Market Share in Volume by Country (2016-2021)
  • Table 74. Europe Intravitreal Injectable Sales by Country (2016-2021) & (US$ Million)
  • Table 75. Europe Intravitreal Injectable Sales Market Share in Value by Country (2016-2021)
  • Table 76. Europe Intravitreal Injectable Sales by Country (2022-2027) & (K Units)
  • Table 77. Europe Intravitreal Injectable Sales Market Share in Volume by Country (2022-2027)
  • Table 78. Europe Intravitreal Injectable Sales by Country (2022-2027) & (US$ Million)
  • Table 79. Europe Intravitreal Injectable Sales Market Share in Value by Country (2022-2027)
  • Table 80. Asia-Pacific Intravitreal Injectable Sales by Region (2016-2021) & (K Units)
  • Table 81. Asia-Pacific Intravitreal Injectable Sales Market Share in Volumeby Region (2016-2021)
  • Table 82. Asia-Pacific Intravitreal Injectable Sales by Region (2016-2021) & (US$ Million)
  • Table 83. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Region (2016-2021)
  • Table 84. Asia-Pacific Intravitreal Injectable Sales by Region (2022-2027) & (K Units)
  • Table 85. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume by Region (2022-2027)
  • Table 86. Asia-Pacific Intravitreal Injectable Sales by Region (2022-2027) & (US$ Million)
  • Table 87. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Region (2022-2027)
  • Table 88. Latin America Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
  • Table 89. Latin America Intravitreal Injectable Sales Market Share in Volume by Country (2016-2021)
  • Table 90. Latin America Intravitreal Injectable Sales by Country (2016-2021) & (US$ Million)
  • Table 91. Latin America Intravitreal Injectable Sales Market Share in Value by Country (2016-2021)
  • Table 92. Latin America Intravitreal Injectable Sales by Country (2022-2027) & (K Units)
  • Table 93. Latin America Intravitreal Injectable Sales Market Share in Volume by Country (2022-2027)
  • Table 94. Latin America Intravitreal Injectable Sales by Country (2022-2027) & (US$ Million)
  • Table 95. Latin America Intravitreal Injectable Sales Market Share in Value by Country (2022-2027)
  • Table 96. Middle East and Africa Intravitreal Injectable Sales by Country (2016-2021) & (K Units)
  • Table 97. Middle East and Africa Intravitreal Injectable Sales Market Share in Volume by Country (2016-2021)
  • Table 98. Middle East and Africa Intravitreal Injectable Sales by Country (2016-2021) & (US$ Million)
  • Table 99. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Country (2016-2021)
  • Table 100. Middle East and Africa Intravitreal Injectable Sales by Country (2022-2027) & (K Units)
  • Table 101. Middle East and Africa Intravitreal Injectable Sales Market Share by Country (2022-2027)
  • Table 102. Middle East and Africa Intravitreal Injectable Sales by Country (2022-2027) & (US$ Million)
  • Table 103. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Country (2022-2027)
  • Table 104. Regeneron Pharmaceuticals (Eylea) Corporation Information
  • Table 105. Regeneron Pharmaceuticals (Eylea) Introduction and Business Overview
  • Table 106. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2020)
  • Table 107. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product
  • Table 108. Genentech Corporation Information
  • Table 109. Genentech Introduction and Business Overview
  • Table 110. Genentech Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2020)
  • Table 111. Genentech Intravitreal Injectable Product
  • Table 112. Allergan (Ozurdex) Corporation Information
  • Table 113. Allergan (Ozurdex) Introduction and Business Overview
  • Table 114. Allergan (Ozurdex) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2020)
  • Table 115. Allergan (Ozurdex) Intravitreal Injectable Product
  • Table 116. EyePoint Pharmaceuticals Corporation Information
  • Table 117. EyePoint Pharmaceuticals Introduction and Business Overview
  • Table 118. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2020)
  • Table 119. EyePoint Pharmaceuticals Intravitreal Injectable Product
  • Table 120. Kanghong Pharmaceutical Corporation Information
  • Table 121. Kanghong Pharmaceutical Introduction and Business Overview
  • Table 122. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2020)
  • Table 123. Kanghong Pharmaceutical Intravitreal Injectable Product
  • Table 124. Key Raw Materials Lists
  • Table 125. Raw Materials Key Suppliers Lists
  • Table 126. Intravitreal Injectable Market Trends
  • Table 127. Intravitreal Injectable Market Drivers
  • Table 128. Intravitreal Injectable Market Challenges
  • Table 129. Intravitreal Injectable Distributors List
  • Table 130. Research Programs/Design for This Report
  • Table 131. Key Data Information from Secondary Sources
  • Table 132. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Intravitreal Injectable Product Picture
  • Figure 2. Global Intravitreal Injectable Market Size, 2016 VS 2021 VS 2027 (US$ Million)
  • Figure 3. Global Intravitreal Injectable Market Size Status and Outlook (2016-2027) & (US$ Million)
  • Figure 4. Global Intravitreal Injectable Sales Status and Outlook (2016-2027) & (K Units)
  • Figure 5. Global Anti-VEGF Sales YoY Growth (2016-2027) & (K Units)
  • Figure 6. Global Steroids Sales YoY Growth (2016-2027) & (K Units)
  • Figure 7. Global Others Sales YoY Growth (2016-2027) & (K Units)
  • Figure 8. Global Intravitreal Injectable Sales by Drug (2016-2027) & (US$ Million)
  • Figure 9. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2016-2021)
  • Figure 10. Global Intravitreal Injectable Sales Market Share in Value by Drug (2016-2021)
  • Figure 11. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2022-2027)
  • Figure 12. Global Intravitreal Injectable Sales Market Share in Value by Drug (2022-2027)
  • Figure 13. Global Macular Degeneration Sales YoY Growth (2016-2027) & (K Units)
  • Figure 14. Global Nacular Edema Sales YoY Growth (2016-2027) & (K Units)
  • Figure 15. Global Uveitis Sales YoY Growth (2016-2027) & (K Units)
  • Figure 16. Global Retinal Vein Occlusion Sales YoY Growth (2016-2027) & (K Units)
  • Figure 17. Global Others Sales YoY Growth (2016-2027) & (K Units)
  • Figure 18. Global Intravitreal Injectable Sales by Disease (2016-2027) & (US$ Million)
  • Figure 19. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2016-2021)
  • Figure 20. Global Intravitreal Injectable Sales Market Share in Value by Disease (2016-2021)
  • Figure 21. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2022-2027)
  • Figure 22. Intravitreal Injectable Manufacturing Cost Structure
  • Figure 23. Intravitreal Injectable Industrial Chain Analysis
  • Figure 24. Porter's Five Forces Analysis
  • Figure 25. Channels of Distribution
  • Figure 26. Distributors Profiles
  • Figure 27. Bottom-up and Top-down Approaches for This Report
  • Figure 28. Data Triangulation
  • Figure 29. Key Executives Interviewed
Back to Top